Shi et al. [41] reported that ACT combined with ICI confers durable anti-tumour responses that depend on CD8+ T-cell-intrinsic expression of ICOS (inducible T-cell costimulatory, a T-cell-specific cell surface molecule). Here, CD8A is linked to neoplasm.